PAVmed Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026

Company Profile

IndustryMedical Devices

SectorHealthcare

ExchangeNASDAQ

Market Capitalization16.75 mln

Float4.15 mln

Earnings Date11/17/2026

Piotroski F-Score

2 / 9

Weak

Beneish M-Score

38.37

Highly suspicious

Relative Strength

11 / 100

Significantly lagging

Debt / Equity

0.49

Low leverage

Pre-Tax Margin

-14,670%

Severely loss-making

ROE

-32.66

Deeply negative

Business Description

PAVmed is a US-based medical company focused on bringing new healthcare solutions to patients with underserved medical needs. Its current offerings include CarpX, a minimally invasive device for treating carpal tunnel syndrome, and EsoCheck and EsoGuard, which work together to detect early signs of esophageal cancer in patients with chronic acid reflux. The company is also developing additional tools for cancer treatment and vascular access. Founded in 2014 and based in New York, PAVmed continues to grow its portfolio of innovative medical technologies.

Key Fundamentals

EPS-14.20

ROE-32.66

RPS0.05

ROIC-62.98

ROA-29.29

Interest Cover-1,484

EBITDA, mln-16.33

EV / EBITDA-1.89

EV / EBIT-1.88

Revenue, mln0.11

EV / Revenue276

Quote Details

Last 2.17

Change 0.12 (5.85%)

Open 2.28

Volume 28,411

Turnover 61,652

Average Volume 20,397

Financial Ratios

Pre-Tax Profit Margin-14,670

Leverage Ratio1.15

Current Ratio1.19

Price / Book1.49

Price / Tangible Book1.49

Debt / Equity0.49

Price / Sales39.67

Financial Strength

Altman Z-Score-9.65

Piotroski F-Score 2 / 9

Beneish M-Score38.37

Short Ratio0.52

Short % of Float0.21

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-9.96%	9 / 100
1 Month	-44.07%	6 / 100
2 Months	-62.52%	5 / 100
6 Months	-75.89%	5 / 100
1 Year	-83.33%	8 / 100